Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.
about
Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysisThe Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine TuberculosisTransformative tools for tackling tuberculosisSystems vaccinology: a promise for the young and the poorProspects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental ResearchTuberculosis vaccines: barriers and prospects on the quest for a transformative toolA nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungsUsing Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis.What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".Whole Blood Profiling of Bacillus Calmette-Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation.The epidemiology of childhood tuberculosis in the Netherlands: still room for prevention.Novel vaccination approaches to prevent tuberculosis in childrenMucosal SIV Vaccines Comprising Inactivated Virus Particles and Bacterial Adjuvants Induce CD8(+) T-Regulatory Cells that Suppress SIV-Positive CD4(+) T-Cell Activation and Prevent SIV Infection in the Macaque Model.A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis.The role of environmental factors in modulating immune responses in early lifeImpact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesBacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosisOral bacillus Calmette-Guérin vaccine against tuberculosis: why not?Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice.The role of B cells and humoral immunity in Mycobacterium tuberculosis infectionFactors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.Impact of tea drinking upon tuberculosis: a neglected issue.Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccineEnvironmental effects of ozone depletion and its interactions with climate change: progress report, 2015.Biological challenges to effective vaccines in the developing worldHuman newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines.Revisiting the Heterogeneous IFN-γ Response of Bacille of Calmette-Guérin (BCG)-Revaccinated Healthy Volunteers in a Randomized Controlled Trial: Effect of the Body Mass Index and of the IFNG+874 A/T PolymorphismUnderstanding immune protection against tuberculosis using RNA expression profilingProtection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4(+) T cells but no increase in avidity for Ag85AA new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality.Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.Vaccination Programs for Endemic Infections: Modelling Real versus Apparent Impacts of Vaccine and Infection Characteristics.
P2860
Q22242062-42B55960-4D09-4F21-B581-85716B84D2D3Q26740410-1B8C35D0-4A2F-4CD8-934F-59B3ECDB35B0Q26784084-DDA947BF-E936-40D3-9914-BF4890460D18Q26862121-D2C1B1D3-6C8B-481B-A0CB-74CDFDE825A4Q28083377-D8F346B3-7FED-4D85-BD12-B3AE3B3D02D6Q28388018-5412CA81-B884-4D33-A9D7-97670B4831B8Q28390218-E413559F-A4E6-452A-A11C-8CA5178364C6Q28396228-0EE9889E-4386-4873-A75B-97D55755E8EBQ31154267-6A470D57-EF58-4064-8C9B-4295E78CB009Q33614952-858825FA-58A4-4FE5-840A-3B98EF963E19Q33624570-4ECB9252-ED40-4BB6-90E4-4C8595CF2D9EQ33679240-D0CF4DAF-08B9-47DB-8AEE-A6F73EDD156DQ33766076-30C882D2-C0FF-41B7-B3C3-B40C2CE82F72Q33796748-5889BE94-5E24-455A-900C-2346548C2D0BQ33801426-B35EF2FE-0C97-4FE9-B255-ACDADDFF765CQ33820903-CB692247-37F5-41F8-A516-EE3E7F138004Q34154197-AD52BB3B-379C-4D35-A92D-C4AF783EDC94Q34169396-3B722CA1-26E5-43FB-A256-8FF171BFC464Q34441930-7A731F4B-C712-4FE4-8C1E-129026DCEE2BQ34479372-BE5F71B8-01DF-49D4-AFAF-A91CB6BD0C17Q34548500-A398F28E-750F-4260-9869-87F8F52E1A66Q34701407-8DECC851-0788-4DE1-A34F-B9A1E5142AC6Q35039807-A6579996-A964-45EA-A8B3-E585635B52F3Q35049474-2B5FFBEF-D184-4452-9AC8-1A839E8EF07FQ35231023-87F54EC7-C42D-4B66-A203-C7FB32DEC70FQ35645396-74462EED-D0F3-4B57-94C6-AAC9544AA389Q35824421-950B3BD8-C946-4787-A84F-3B5FB4DCB11AQ35887180-17C0BB86-A8FF-42A4-9651-30D58D981ED2Q35907709-00440B97-65F9-4C1A-BDE8-BD63DA2D25B4Q35923822-1F0EA1EA-6216-4FC1-B0B4-E6451E489FBEQ36018901-07ED115B-FC99-4013-A35F-DC5F27056E11Q36035900-005FA544-47FE-474B-946C-90A04FD5F789Q36089561-18ECB86D-7617-4D4F-ADD7-E6CE8912E57DQ36092310-14299CD0-AA06-4546-8DF4-19DC1266627AQ36096965-4BC1950B-3583-45CF-9872-2233FDDBD5A0Q36103177-C465DB6D-0A06-4DAF-91C7-C13A2F185981Q36135067-B872FE62-8218-4920-930C-FF93713068A0Q36145561-25286809-A60F-4E42-AB74-22840E17150EQ36145657-3385A556-49F3-4234-8F31-E8BE9BF05CC0Q36180041-702AEFC8-CFB8-4011-9791-5C7CD6200CE4
P2860
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Protection by BCG vaccine agai ...... randomized controlled trials.
@en
type
label
Protection by BCG vaccine agai ...... randomized controlled trials.
@en
prefLabel
Protection by BCG vaccine agai ...... randomized controlled trials.
@en
P2093
P2860
P50
P356
P1476
Protection by BCG vaccine agai ...... randomized controlled trials.
@en
P2093
Cono Ariti
Laura Pimpin
Marc Lipman
Paul E M Fine
Punam Mangtani
Rebecca Beynon
P2860
P304
P356
10.1093/CID/CIT790
P407
P577
2013-12-13T00:00:00Z